Guest author Olga Gurgula is a Senior Lecturer in Intellectual Property Law at Brunel Law School, Brunel University London.
A war-weary Ukraine critically depends on the support of...
We are reaching the end of 2018: Time for our end-of-the-year roundup of some significant developments in medicines law and policy.
January
The Chilean parliament started...
The European Commission has been heavily criticised for its performance over Covid-19 vaccine supply to European Union Member States. Despite the urgency of the...
During the Covid-19 pandemic, the United States prioritised the rapid development of products needed to combat the health crisis. Rapid product development was pursued...
The Medicines Patent Pool, a United Nations-backed public health organisation, today announced its second Covid-related voluntary licence agreement. The agreement will enable low-cost production...
On 14 May 2020, Medicines Law & Policy together with Health Action International, WEMOS, The Foundation for Pharmaceutical Accountability and Knowledge Ecology International held...
Welcome to our 2023 end-of-the-year blog, our annual and highly-biased run-through of notable access to medicines events of the year that is about to...
On 6 December, Knowledge Ecology International (KEI) organised an interesting panel on the patentability of new gene- and cell-based medical therapies, as a side...